Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 358

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

Assessment of Endovascular Treatment for Acute Basilar Artery Occlusion via a Nationwide Prospective Registry

Open access
Writing Group for the BASILAR Group, Zi, Wenjie, Qiu, Zhongming, Wu, Deping, Li, Fengli, Liu, Hansheng, Liu, Wenhua, Huang, Wenguo, Shi, Zhonghua, Bai, Yongjie, Liu, Zhensheng, Wang, Li, Yang, Shiquan, Pu, Jie, Wen, Changming, Wang, Shouchun, Zhu, Qiyi, Chen, Wenhuo, Yin, Congguo, Lin, Min, Qi, Li, Zhong, Yaoyi, Wang, Zhen, Wu, Wenjun, Chen, Huisheng, Yao, Xiaoxi, Xiong, Feng, Zeng, Guoyong, Zhou, Zhiming, Wu, Zhilin, Wan, Yue, Peng, Huiyuan, Li, Bing, Hu, Xinping, Wen, Hongbin, Zhong, Wangtao, Wang, Leyuan, Jin, Ping, Guo, Fuqiang, Han, Ju, Fu, Xinmin, Ai, Zhibing, Tian, Xiguang, Feng, Xiaoya, Sun, Bo, Huang, Zhizhi, Li, Wei, Zhou, Peiyang, Tu, Mingyi, Sun, Xiangrong, Li, Hua, He, Wencheng, Qiu, Tao, Yuan, Zhengzhou, Yue, Chengsong, Yang, Jun, Luo, Weidong, Gong, Zili, Shuai, Jie, Nogueira, Raul Gomes, Yang, Qingwu·2020·JAMA Neurology

Abstract

Importance: Several randomized clinical trials have recently established the safety and efficacy of endovascular treatment (EVT) of acute ischemic stroke in the anterior circulation. However, it remains uncertain whether patients with acute basilar artery occlusion (BAO) benefit from EVT. Objective: To evaluate the association between EVT and clinical outcomes of patients with acute BAO. Design, Setting, and Participants: This nonrandomized cohort study, the EVT for Acute Basilar Artery Occlusion Study (BASILAR) study, was a nationwide prospective registry of consecutive patients presenting with an acute, symptomatic, radiologically confirmed BAO to 47 comprehensive stroke centers across 15 provinces in China between January 2014 and May 2019. Patients with acute BAO within 24 hours of estimated occlusion time were divided into groups receiving standard medical treatment plus EVT or standard medical treatment alone. Main Outcomes and Measures: The primary outcome was the improvement in modified Rankin Scale scores (range, 0 to 6 points, with higher scores indicating greater disability) at 90 days across the 2 groups assessed as a common odds ratio using ordinal logistic regression shift analysis, adjusted for prespecified prognostic factors. The secondary efficacy outcome was the rate of favorable functional outcomes defined as modified Rankin Scale scores of 3 or less (indicating an ability to walk unassisted) at 90 days. Safety outcomes included symptomatic intracerebral hemorrhage and 90-day mortality. Results: A total of 1254 patients were assessed, and 829 patients (of whom 612 were men [73.8%]; median [interquartile] age, 65 [57-74] years) were recruited into the study. Of these, 647 were treated with standard medical treatment plus EVT and 182 with standard medical treatment alone. Ninety-day functional outcomes were substantially improved by EVT (adjusted common odds ratio, 3.08 [95% CI, 2.09-4.55]; P < .001). Moreover, EVT was associated with a significantly higher rate of 90-day modified Rankin Scale scores of 3 or less (adjusted odds ratio, 4.70 [95% CI, 2.53-8.75]; P < .001) and a lower rate of 90-day mortality (adjusted odds ratio, 2.93 [95% CI, 1.95-4.40]; P < .001) despite an increase in symptomatic intracerebral hemorrhage (45 of 636 patients [7.1%] vs 1 of 182 patients [0.5%]; P < .001). Conclusions and Relevance: Among patients with acute BAO, EVT administered within 24 hours of estimated occlusion time is associated with better functional outcomes and reduced mortality.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1001/jamaneurol.2020.0156

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 29 references

Cited by

See all 358

Metadata

Authors
Writing Group for the BASILAR Group, Zi, W., Qiu, Z., Wu, D., Li, F., Liu, H., Liu, W., Huang, W., Shi, Z., Bai, Y., Liu, Z., Wang, L., Yang, S., Pu, J., Wen, C., Wang, S., Zhu, Q., Chen, W., Yin, C., Lin, M., Qi, L., Zhong, Y., Wang, Z., Wu, W., Chen, H., Yao, X., Xiong, F., Zeng, G., Zhou, Z., Wu, Z., Wan, Y., Peng, H., Li, B., Hu, X., Wen, H., Zhong, W., Wang, L., Jin, P., Guo, F., Han, J., Fu, X., Ai, Z., Tian, X., Feng, X., Sun, B., Huang, Z., Li, W., Zhou, P., Tu, M., Sun, X., Li, H., He, W., Qiu, T., Yuan, Z., Yue, C., Yang, J., Luo, W., Gong, Z., Shuai, J., Nogueira, R. G., & Yang, Q.
Venue
JAMA Neurology
Published
2020-05-01
Volume
77
Issue
5
Pages
561
ISSN
2168-6149 (ISSN-L)
OpenAlex
W3006941819
Cited by
358
References
29
FWCI
34.87
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Assessment of Endovascular Treatment for Acute Basilar Artery Occlusion via a Nationwide Prospective Registry. https://app.cochat.ai/papers/10.1001/jamaneurol.2020.0156
The paper
Writing Group for the BASILAR Group, Zi, W., Qiu, Z., Wu, D., Li, F., Liu, H., Liu, W., Huang, W., Shi, Z., Bai, Y., Liu, Z., Wang, L., Yang, S., Pu, J., Wen, C., Wang, S., Zhu, Q., Chen, W., Yin, C., . . . Yang, Q. (2020). Assessment of Endovascular Treatment for Acute Basilar Artery Occlusion via a Nationwide Prospective Registry. JAMA Neurology. https://doi.org/10.1001/jamaneurol.2020.0156

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.